Immunostimulatory colloidal delivery systems for cancer vaccines

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Immunostimulatory colloidal delivery systems for cancer vaccines. / Saupe, Anne; McBurney, Warren; Rades, Thomas; Hook, Sarah.

In: Expert Opinion on Drug Delivery, Vol. 3, No. 3, 2006, p. 345-54.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Saupe, A, McBurney, W, Rades, T & Hook, S 2006, 'Immunostimulatory colloidal delivery systems for cancer vaccines', Expert Opinion on Drug Delivery, vol. 3, no. 3, pp. 345-54. https://doi.org/10.1517/17425247.3.3.345

APA

Saupe, A., McBurney, W., Rades, T., & Hook, S. (2006). Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opinion on Drug Delivery, 3(3), 345-54. https://doi.org/10.1517/17425247.3.3.345

Vancouver

Saupe A, McBurney W, Rades T, Hook S. Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opinion on Drug Delivery. 2006;3(3):345-54. https://doi.org/10.1517/17425247.3.3.345

Author

Saupe, Anne ; McBurney, Warren ; Rades, Thomas ; Hook, Sarah. / Immunostimulatory colloidal delivery systems for cancer vaccines. In: Expert Opinion on Drug Delivery. 2006 ; Vol. 3, No. 3. pp. 345-54.

Bibtex

@article{6647d1e903f3489f832923a10b8ddb6b,
title = "Immunostimulatory colloidal delivery systems for cancer vaccines",
abstract = "Cancer vaccine delivery is a multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, such as colloidal immunostimulatory delivery systems. The importance of formulation strategies for cancer vaccines can be explained by the poor immunogenicity of tumour antigens. Colloidal vaccine delivery systems modify the kinetics, body distribution, uptake and release of the vaccine. This review explores recent research that is directed towards more targeted treatments of cancer through to colloidal vaccine delivery systems. Widely investigated carrier systems include polymeric micro- and nanoparticles, liposomes, archaeal lipid liposomes (archaeosomes), immune-stimulating complexes and virus-like particles. These systems are evaluated in terms of their formulation techniques, immunological mechanisms of action as well as the potential and limitations of such colloidal systems in the field of cancer vaccines.",
author = "Anne Saupe and Warren McBurney and Thomas Rades and Sarah Hook",
year = "2006",
doi = "10.1517/17425247.3.3.345",
language = "English",
volume = "3",
pages = "345--54",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Immunostimulatory colloidal delivery systems for cancer vaccines

AU - Saupe, Anne

AU - McBurney, Warren

AU - Rades, Thomas

AU - Hook, Sarah

PY - 2006

Y1 - 2006

N2 - Cancer vaccine delivery is a multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, such as colloidal immunostimulatory delivery systems. The importance of formulation strategies for cancer vaccines can be explained by the poor immunogenicity of tumour antigens. Colloidal vaccine delivery systems modify the kinetics, body distribution, uptake and release of the vaccine. This review explores recent research that is directed towards more targeted treatments of cancer through to colloidal vaccine delivery systems. Widely investigated carrier systems include polymeric micro- and nanoparticles, liposomes, archaeal lipid liposomes (archaeosomes), immune-stimulating complexes and virus-like particles. These systems are evaluated in terms of their formulation techniques, immunological mechanisms of action as well as the potential and limitations of such colloidal systems in the field of cancer vaccines.

AB - Cancer vaccine delivery is a multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, such as colloidal immunostimulatory delivery systems. The importance of formulation strategies for cancer vaccines can be explained by the poor immunogenicity of tumour antigens. Colloidal vaccine delivery systems modify the kinetics, body distribution, uptake and release of the vaccine. This review explores recent research that is directed towards more targeted treatments of cancer through to colloidal vaccine delivery systems. Widely investigated carrier systems include polymeric micro- and nanoparticles, liposomes, archaeal lipid liposomes (archaeosomes), immune-stimulating complexes and virus-like particles. These systems are evaluated in terms of their formulation techniques, immunological mechanisms of action as well as the potential and limitations of such colloidal systems in the field of cancer vaccines.

U2 - 10.1517/17425247.3.3.345

DO - 10.1517/17425247.3.3.345

M3 - Journal article

C2 - 16640495

VL - 3

SP - 345

EP - 354

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 3

ER -

ID: 40357500